Adequacy of blood pressure control and level of adherence with antihypertensive therapy

East African Medical Journal

Volumn 86, Issue 11, 2009, Pages 499-506

  Achieng', L ^a   Joshi, M D ^a   Ogola, E N ^a   Karari, E ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957608620     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Opie, L. H. and Seedat, Y. K. Hypertension in sub- Saharan African populations. Circulation. 2005; 112: 3562-3568.
2. Sanicki, P. and Gauran, N.M. Have ALLHA T, ANBP2, ASCOT -BPLA and so forth improved our knowledge about better hypertension care? Hypetension. 2006; 48: 1-7.
3. Chobanian, A.V., Bakris, G.L., Black, H.R., et al. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. J. Am. Med. Assoc. 2003; 289: 2560-2572.
4. Whelton, P.K., He, J. and Muntner, P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J. Hum. Hypertens. 2004; 18: 545-551.
5. Cappucio, F., Micah, F., Emmett, L., et al. Prevalence, detection, management and control of hypertension in Ashanti, West Africa. Hypertension. 2004; 43: 1017-1022.
6. Bovet, P., Ross, A., Gervasoni, J., et al. Distribution of blood pressure, BMI and smoking habits in the urban population of Dar es Salaam, Tanzania and associations with socioeconomic status. Int J. Epid. 2002; 31: 240-247.
7. Thrall, G., Lip, G.Y.H. and Lane, D. Compliance with pharmacologic therapy in hypertension: Can we do better, and how? J. Hum. Hypertens. 2004; 18: 595-597.
8. Burnier, M., Santschi, V., Favrat, B. and Brunner, H.R. Monitoring compliance in resistant hypertension: an important step in patient management. J. Hypertens. 2003; 21(suppl 2): S37-S42.
9. Hamilton, G.A. Measuring adherence in a hypertension clinical trial. Eur. J. Cardiovasc. Nur. 2003; 2: 219-228.
10. Krousel-Wood, M., Thomas, S., Muntner, P. and Morisky, D. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr. Opin. Cardiol. 2004; 19: 357-362:219-228.
11. Kim, T.M., Hill, M.N., Bone, L.R. and Levine, O.M. Development and testing of the Hill-Bone compliance to high BP therapy scale. Prog. Cardiovasc. Nurs. 2000; 15: 90-96.
12. Schoberberger, R., Janda, M., Pescosta, W. and Sonneck, G. The Compliance Praxis Survey (COMPASS): a multidimensional instrument to monitor compliance for patients on antihypertensive medication. J. Hum. Hypertens. 2002; 16: 779-787.
13. Lambert, E., Steyn, K., Stender, S., et al. Cross-cultural validation of the HiII-Bone compliance with high blood pressure therapy scale in a South African, primary health care setting. Ethn. Dis. 2006; 16: 286-291.
14. Guideline Subcommittee: 1999 World health Organization-International society of hypertension guidelines for the management of hypertension. J. Hypertens. 1999; 17: 151-183.
15. Edwards, R., Unwin, N., Mugusi, F., et al. Hypertension prevalence and care in an urban and rural area of Tanzania. J. Hypertens. 2000; 18: 145-152.
16. Weinehall, L., Ohgren, B., Persson, M., et al. High remaining risk in poorly treated hypertension; the 'Rule of Halves' still exists. J. Hypertens. 2002; 20: 2081-2088.
17. Cushman, W.C., Ford, C.E., Cutler, J.A., et al. Major outcomes in high-risk hypertensive patients randomized to ACE-l or CCB vs diuretic-The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J. Am. Med Assoc. 2002; 288: 2981-2997.
18. Kjeldsen, E., Hedner, T., Jamerson, K., et al. Hypertension optimal treatment study, home BP in treated hypertensive patients. Hypertension. 1998; 31: 1014-1020.
19. Black, H.R., Elliot, W. J., Neaton, J.D., Grandits, G. and Grambusch P. for the CONVINCE research group. control in the CONVINCE Trial. Hypertension. 2001; 37: 12-18.
20. Singer, M. G., Izhar, M. and Black, H. Goal-oriented hypertension management-translating clinical trials to practice. Hypertension. 2002; 40: 464-469.
21. Degli, E., Berto, P., Buda, S., et al. PANDORA project. J. Hum. Hypertens. 2008; 22: 51-53.
22. Ibrahim, M.M., Rick, H., Appel, L., et al. Hypertension prevalence, awareness, treatment and control in Egypt. Results from the Egyptian National Hypertension Project. NHP investigative team. Hypertension. 1995; 26: 886-890.
23. Steyn, K., Fourie, J., Lombard, C., et al. Hypertension in the black community of Cape Peninsula, South Africa. East Afr. Med. J. 1996; 73: 758-763.
24. Agyemang, C., Bruignzeels, M. A. and Owusu- Dabo, E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J. Hum. Hypertens. 2006; 20: 67-71.
25. Borzecki, A., Wong, A., Hickey, E. et al. Hypertension control. how well are we doing? Arch. Intern. Med. 2003; 163: 2705-2711.
26. Nelson, M.R., Reis, M.C., Ryan, P., et al. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study. MJA 2006; 185: 487-489.
27. Siegel, D., Lopez, J. and Meier, J. Antihypertensive medication adherence in the department of veterans affairs. Am J. Med. 2007; 120: 26-32.
28. Ross, S., Walker, A. and MacLeod, M.J. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J. Hum. Hypertens. 2004; 18: 607-613.
29. Whelton, P.K., Appel, L.J., Espeland, M.A., et al. (for TONE collaboration group) Sodium restriction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of non phannacologic intervention in the elderly. J. Am. Med. Assoc. 1998; 279: 839-846.
30. Okonofua, E., Simpson, K., Jesri, A., et al. Therapeutic inertia is an impediment to achieving the healthy people 2010 BP control goals. Hypertension. 2006; 47: 345- 351.